# Sandro Barni

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sandro-barni/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,725 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 77 |
| i10-index | 366 |
| Last Known Institution | Azienda Ospedaliera Treviglio |
| OpenAlex ID | https://openalex.org/A5061179981 |
| ORCID iD | https://orcid.org/0000-0002-7633-0378 |
| Works | 780 |

## Researcher papers

- [Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study](https://scholariq.org/papers/nadroparin-for-the-prevention-of-thromboembolic-events-in-ambulatory-patients/)
- [FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer](https://scholariq.org/papers/folfoxiri-plus-bevacizumab-as-conversion-therapy-for-patients-with-initially/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Circadian rhythm and melatonin](https://scholariq.org/topics/circadian-rhythm-and-melatonin/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Azienda Ospedaliera Treviglio](https://scholariq.org/institutions/azienda-ospedaliera-treviglio/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.